JAYEX Healthcare Ltd (JHL)
20mins delayed
Movement
1 Year Return
JAYEX Healthcare Ltd Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $8.05 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
JHL Statistics
21 January
2,151 / 2,257
ASX Size Rank
1yr Return
vs Sector (1yr)
+21.70%
vs ASX 200 (1yr)
+37.67%
$8.05 million
Market Cap
Share Issue
201.36 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
21 January
N/A
PE Ratio
EPS ($)
-0.003
Earnings Yield
-8.50%
NTA ($)
-0.03
0.00%
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Jayex Healthcare Limited (JHL) is a provider in the United Kingdom and Australia of integrated healthcare services delivery platforms, incorporating the Company's four interconnected and proprietary technologies, being: Enlighten patient workflow platform; Appointuit patient engagement solution; Pharmacy Delivery and BluePoint remote pharmacy prescription processing and dispensing terminal.
Upcoming Calendar
| 26 Feb 2021 | Report (Prelim) |
| 23 Mar 2021 | Report (Annual) |
| 27 Aug 2021 | Report (Interim) |
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Announcements provided by
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
JHL is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Mr Michael Denis Boyd | Executive Chairman, Executive Director | May 2017 |
|
| Mr Brian Renwick | Non-Executive Director | Jul 2009 |
|
| Mr Michael Chan | Non-Executive Director | Mar 2017 |
|
| Mr Nicholas Harper | Non-Executive Director | Sep 2020 |
|
| Nathan Woodard | Chief Financial Officer | N/A | |
| Melanie Jaye Leydin | Company Secretary | N/A |
Director Transactions
JHL directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 13/10/20 | Michael Boyd | Buy | +3,000,000 | $0.050 | $150,000 | As advised by the company. |
| 30/09/20 | Michael Boyd | Buy | +1,500,000 | $0.035 | $52,500 | On-market trade. |
| 30/06/20 | Michael Chan | Buy | +24,962 | $0.018 | $449 | On-market trade. |
| 29/06/20 | Michael Chan | Buy | +123,648 | $0.018 | $2,225 | On-market trade. |
| 13/11/19 | Michael Boyd | Buy | +150,000 | $0.039 | $5,790 | On-market trade. |
| 12/11/19 | Michael Boyd | Buy | +64,831 | $0.039 | $2,502 | On-market trade. |
| 04/04/19 | Michael Boyd | Buy | +57,541 | $0.035 | $2,013 | On-market trade. |
| 02/04/19 | Michael Boyd | Buy | +23,199 | $0.035 | $811 | On-market trade. |
| 29/03/19 | Michael Boyd | Buy | +19,128 | $0.035 | $669 | On-market trade. |
| 29/03/19 | Michael Boyd | Buy | +1,928 | $0.035 | $67 | On-market trade. |
| 28/03/19 | Michael Boyd | Buy | +71,487 | $0.035 | $2,502 | On-market trade. |
| 27/03/19 | Michael Boyd | Buy | +28,645 | $0.035 | $1,002 | On-market trade. |
| 26/03/19 | Michael Boyd | Buy | +101,173 | $0.035 | $3,541 | On-market trade. |
| 25/03/19 | Michael Boyd | Buy | +98,827 | $0.035 | $3,458 | On-market trade. |
| 13/09/18 | Michael Chan | Buy | +200,000 | $0.019 | $3,800 | On-market trade. |
| 05/06/18 | Michael Chan | Buy | +55,315 | $0.024 | $1,327 | On-market trade. |
| 04/06/18 | Michael Boyd | Issued | 3,481,055 | $0.020 | $69,272 | Director remuneration. |
| 04/06/18 | Brian Renwick | Issued | 1,130,653 | $0.020 | $22,499 | Director remuneration. |
| 04/06/18 | Michael Chan | Issued | 1,005,025 | $0.020 | $19,999 | Director remuneration. |
| 04/06/18 | Michael Chan | Buy | +100,000 | $0.021 | $2,100 | On-market trade. |
| 04/06/18 | Agam Jain | Issued | 3,123,417 | $0.020 | $62,155 | Director remuneration. |
| 01/06/18 | Agam Jain | Buy | +226,156 | $0.020 | $4,523 | On-market trade. |
| 29/05/18 | Michael Chan | Buy | +44,685 | $0.019 | $849 | On-market trade. |
| 20/04/18 | Agam Jain | Buy | +749,110 | $0.018 | $13,483 | On-market trade. |
| 06/04/18 | Michael Boyd | Transfer | 6,505,530 | $0.019 | $123,605 | Off-market transfer. |
| 29/09/17 | Michael Boyd | Buy | +22,838 | $0.023 | $525 | On-market trade. |
| 26/09/17 | Michael Boyd | Buy | +14,831 | $0.023 | $341 | On-market trade. |
| 25/09/17 | Michael Boyd | Buy | +100,000 | $0.022 | $2,200 | On-market trade. |
| 19/09/17 | Michael Boyd | Buy | +73,780 | $0.022 | $1,623 | On-market trade. |
| 18/09/17 | Michael Boyd | Buy | +26,220 | $0.022 | $576 | On-market trade. |
| 30/06/17 | Michael Boyd | Buy | +572,500 | $0.022 | $12,750 | On-market trade. |
| 11/05/17 | Michael Chan | Transfer | 150,000 | $0.020 | $3,000 | Off-market transfer. |
| 11/05/17 | Michael Chan | Buy | +150,000 | $0.020 | $3,000 | On-market trade. |
| 08/12/16 | Brian Renwick | Buy | +20,000 | $0.052 | $1,040 | |
| 27/09/16 | Agam Jain | Buy | +70,000 | $0.078 | $5,460 | |
| 26/09/16 | Agam Jain | Buy | +3,875 | $0.080 | $310 | |
| 16/09/16 | Agam Jain | Buy | +6,125 | $0.078 | $477 | |
| 12/09/16 | Agam Jain | Buy | +130,000 | $0.078 | $10,140 | |
| 13/05/16 | Michael Boyd | Buy | +160,050 | $0.196 | $31,351 | |
| 09/05/16 | Michael Boyd | Buy | +26,250 | $0.200 | $5,250 | |
| 05/05/16 | Michael Boyd | Buy | +6,250 | $0.200 | $1,250 | |
| 04/05/16 | Michael Boyd | Buy | +150,000 | $0.200 | $30,000 | |
| 03/05/16 | Michael Boyd | Buy | +20,000 | $0.200 | $4,000 | |
| 02/05/16 | Michael Boyd | Buy | +100,000 | $0.209 | $20,900 | |
| 01/04/16 | Michael Boyd | Buy | +3,450 | $0.220 | $759 | |
| 31/03/16 | Michael Boyd | Buy | +84,000 | $0.225 | $18,900 |
Shareholder Distribution
| Holding Size | 1 - 1,000 | 1,001 - 5,000 | 5,001 - 10,000 | 10,001 - 100,000 | 100,001 and over | Total Shareholders |
|---|---|---|---|---|---|---|
| No. of Shareholders | 16 | 37 | 96 | 160 | 103 | 412 |
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| Covenant Holdings(Wa)Pty Ltd (Boyd#4 A/C) | 77,912,910 | 44.18% |
| Vector London Ltd | 19,003,378 | 10.78% |
| Mr John Clive Allinson | 6,580,530 | 3.73% |
| Mr Nicholas Fernando | 5,000,000 | 2.84% |
| Mr Dean Henry Cleary (The Clearway Investment A/C) | 4,140,000 | 2.35% |
| Mr Agam Jain | 3,337,927 | 1.89% |
| Donovan Products Pty Ltd (Family Account) | 2,746,916 | 1.56% |
| Mr Mun Kee Chang | 2,651,433 | 1.50% |
| Mr Robert John Mantel & Mrs Fiona Mantel (R & F Mantel Super Fund A/C) | 2,250,000 | 1.28% |
| Citicorp Nominees Pty Limited | 2,218,124 | 1.26% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 1,801,365 | 1.02% |
| Amg Corporate Pty Ltd (The Amg Super Fund A/C) | 1,705,025 | 0.97% |
| Mr Dennis Craig Telford | 1,700,000 | 0.96% |
| Mr Peter Howells | 1,558,243 | 0.88% |
| Ms Mandy Jean Rutherford | 1,408,000 | 0.80% |
| Dr Choonjoo Kho | 1,307,000 | 0.74% |
| Miss Olga Osipova | 1,297,946 | 0.74% |
| A & D Holdings 2 Pty Ltd (A & D Hill Superfund A/C) | 1,262,587 | 0.72% |
| Dennis Joseph Mcmahon | 1,250,000 | 0.71% |
| Franz Anton Strydom | 1,250,000 | 0.71% |
| Wayne Edward Beilby | 1,250,000 | 0.71% |
| Mr Brian Patrick Renwick | 1,227,840 | 0.70% |
| All other shareholders | 18.97 % | |
The Top 20 Shareholders of JHL hold 81.03% of shares on issue.
JHL Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
JHL Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|---|---|
| 2020 | $0.018 | 30 June |
| 2019 | $0.048 | 28 June |
| 2018 | $0.025 | 29 June |
| 2017 | $0.023 | 28 June |
| 2016 | $0.145 | 28 June |
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Development and provision of healthcare industry service technologies and the development of integrated dispensing automation systems for the pharmaceutical and healthcare sectors.
Incorporated: --
17B Cribb St
Milton QLD 4064
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.